PRE-MARKET MOVERS
1. OCUL, REGN: $OCUL Ocular Therapeutix Inks Licensing Deal With Regeneron $REGN For Wet AMD – Xconomy
5. VIA, VIAB: $VIAB BofA/Merrill Lynch Upgrades Viacom $VIA to Buy, $44 PT Wells Fargo Upgrades to Market Perform
15. MRK: $MRK Merck KgaA To Meet 2018 Targets; Sees EUR 4 Bln Sales From New Products By 2022 – nasdaq
22. CSIQ, LMRK: $CSIQ Landmark Infrastructure $LMRK to Acquire California Land Assets from Canadian Solar Unit – SI
29. AMZN, GPRO: $GPRO GoPro Sees Early Weakness as Company Temporarily Stops Shipping to Amazon $AMZN – Street Insider
35. MELI: $MELI MercadoLibre, Inc. Announces Proposed Follow-on Offering by Stockholders – Econo Times
UPGRADES
3. BMY, MRK:$MRK upgraded to Buy from Neutral at BofA/Merrill, PT $70. $BMY
7. HCA:$HCA – *MW HCA Holdings upgraded to overweight from sector weight at KeyBanc Capital
8. MSFT:$MSFT upgraded to Buy at Zacks Research – PT $64
15. VIA, VIAB:$VIAB BofA/Merrill Lynch Upgrades Viacom $VIA to Buy, $44 PT Wells Fargo Upgrades to Market Perform
DOWNGRADES
1. BMY:$BMY downgraded to Buy from Conviction Buy at Goldman Sachs
EARNINGS
Trending Social Alerts
1. OCUL:$OCUL and $REGN Collaboration To Develop Sustained Release Formulation Of Aflibercept For The Treatment Of Wet AMD And Other RetinalDiseases
2. DAL:#BREAKING: Delta Air Lines $DAL Q3 Revenue, $10.48B vs. $10.55B expected
3. TGTX:$TGTX Amends the GENUINE Phase 3 Clinical Trial to Accelerate Study Completion by Revising Primary Endpoint to Overall Response Rate
4. AMRS:$AMRS – $20M equity investment @ $1.40. $100M in annual revenues starting in 2017. Deal more than doubles annual revenue
7. OGXI:$OGXI halt
8. BMRN:$BMRN apparently believes by FDA’s own analysis drisa’s dystrophin data stronger than $SRPT. What ar…
Trending News Headlines
1. Bluebird Bio showcases upgraded gene therapy for rare blood diseases
2. Bempedoic Acid Global Phase 3 Clinical Program to Include Patients on Any Statin at Any Dose
3. Ulta Beauty Hosts Analyst and Investor Conference and Raises Third Quarter and Fiscal Year 2016 Guidance
4. Event Details | Investor Relations | Bluebird Bio
5. Press Release | Investor Relations | Bluebird Bio
6. bluebird bio Provides Update on LentiGlobin™ Programs and Research and Development Strategy at Gene Therapy Day | Business Wire
7. Amazon Hiring 120,000 For The Holidays (NASDAQ:AMZN)
8. Georgi Kantchev on Twitter
“Oil at $70/b is too hot, and $50/b too cold for U.S. shale, says @CreditSuisse”
9. Amazon to hire 120,000 temporary workers for holiday season
10. Deutsche Bank alerts managers to hiring freeze: source